Tramazoline
RESPIRATORY SYSTEM
Also known as: rhinol, tramazoline HCl, tramazoline hydrochloride
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Tramazoline is a drug catalogued in DrugCentral. DrugCentral lists 5 molecular targets, including Adra2b|Adra2c|Adra2a, ADRA2A and ADRA2B. Recorded indications include Allergic conjunctivitis, Allergic rhinitis, Common cold and Nasal congestion.
- Molecular targets: Adra2b|Adra2c|Adra2a, ADRA2A, ADRA2B and ADRA2C (5 listed in DrugCentral).
- Indications: Allergic conjunctivitis, Allergic rhinitis, Common cold, Nasal congestion and Nasal discharge and others.
- ATC code: R01AA09 (Sympathomimetics, plain).
- Molecular formula: C13H17N3; molecular weight 215.30 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (8)
- Allergic conjunctivitis
- Allergic rhinitis
- Common cold
- Nasal congestion
- Nasal discharge
- Seasonal allergic rhinitis
- Sneezing
- Vasomotor rhinitis
Contraindications (10)
- Angle-closure glaucoma
- Benign prostatic hyperplasia
- Bladder outflow obstruction
- Chronic idiopathic constipation
- Chronic obstructive lung disease
- Gastrointestinal obstruction
- Hypertensive disorder
- Hyperthyroidism
- Peptic ulcer
- Retention of urine
Mechanism & targets
Molecular targets (5)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Adrenergic receptor alpha-2 | Adra2b|Adra2c|Adra2a | unknown | Ki 8.38 |
| Alpha-2A adrenergic receptor | ADRA2A | unknown | Ki 7.50 |
| Alpha-2B adrenergic receptor | ADRA2B | unknown | Ki 6.86 |
| Alpha-2C adrenergic receptor | ADRA2C | unknown | Ki 6.56 |
| Adrenergic receptor alpha-1 | Adra1b|Adra1d|Adra1a | unknown | IC50 5.96 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
R01AA09 | RESPIRATORY SYSTEM › NASAL PREPARATIONS › DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE › Sympathomimetics, plain |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Tramazoline is on its molecule page.
| Molecular formula | C13H17N3 |
|---|---|
| Molecular weight | 215.30 g/mol |
| CAS number | 1082-57-1 |
| InChIKey | QQJLHRRUATVHED-UHFFFAOYSA-N |
| PubChem CID | 5524 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Tramazoline used for?
DrugCentral lists the following indications for Tramazoline: Allergic conjunctivitis, Allergic rhinitis, Common cold, Nasal congestion, Nasal discharge, Seasonal allergic rhinitis, Sneezing and Vasomotor rhinitis.
How does Tramazoline work?
Its molecular targets in DrugCentral include Adra2b|Adra2c|Adra2a, ADRA2A, ADRA2B and ADRA2C.
What is the chemical formula of Tramazoline?
Tramazoline has the molecular formula C13H17N3 and a molecular weight of 215.30 g/mol.
Browse: all drugs starting with T · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3620 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2107640 — compound record and bioactivity
- PubChem CID 5524 — chemical identifiers
- DrugBank DB13064 — drug record
- FDA UNII SLE31693IV — substance identity
- UniProt P08913 (ADRA2A) — target protein
- UniProt P18089 (ADRA2B) — target protein
- UniProt P18825 (ADRA2C) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.